Natalie Mount
Director/Miembro de la Junta en Rinri Therapeutics Ltd. .
Cargos activos de Natalie Mount
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Rinri Therapeutics Ltd.
 Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom. | Director/Miembro de la Junta | - | - |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Director/Miembro de la Junta | 10/05/2023 | - |
| Presidente | 25/08/2022 | 10/05/2023 | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Inversor de Capital Privado | 01/08/2022 | - |
Historial de carrera de Natalie Mount
Antiguos cargos conocidos de Natalie Mount.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Adaptate Biotherapeutics Ltd.
 Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | 21/08/2019 | 26/04/2022 |
| Director Ejecutivo | - | 26/04/2022 | |
| GENSIGHT BIOLOGICS S.A. | Director/Miembro de la Junta | 31/05/2017 | 16/05/2021 |
| Independent Dir/Board Member | 31/05/2017 | 16/05/2021 | |
| Chimeric Therapeutics Ltd. | Director/Miembro de la Junta | - | - |
Cell Therapy Catapult Ltd.
 Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | - | - |
| Director Técnico/Científico/I+D | - | - | |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Director Técnico/Científico/I+D | 01/01/2017 | - |
Formación de Natalie Mount.
| University of Cambridge | Undergraduate Degree |
| University College London | Doctorate Degree |
Estadísticas
Internacional
| Reino Unido | 9 |
| Francia | 2 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 6 |
| Chief Tech/Sci/R&D Officer | 2 |
| Independent Dir/Board Member | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Empresas privadas | 7 |
|---|---|
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Finance |
Cell Therapy Catapult Ltd.
Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
Gammadelta Therapeutics Ltd.
Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Health Technology |
| Chimeric Therapeutics Ltd. | Health Technology |
Rinri Therapeutics Ltd.
Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom. | Commercial Services |
Adaptate Biotherapeutics Ltd.
Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Commercial Services |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Technology Services |
- Bolsa de valores
- Insiders
- Natalie Mount
- Experiencia
